| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |